Attached files

file filename
8-K - CURRENT REPORT - QUAKER CHEMICAL CORPv305044_8k.htm
EX-99.2 - SUPPLEMENTAL INFORMATION RELATED TO FOURTH QUARTER ENDED DECEMBER 31 2011 - QUAKER CHEMICAL CORPv305044_ex99-2.htm

Quaker Chemical Announces Fourth Quarter and Full Year 2011 Results

CONSHOHOCKEN, Pa., March 7, 2012 /PRNewswire/ --

  • Record full year net sales and earnings in 2011 due to higher volumes and acquisitions
  • Fourth quarter sales up 22% vs. 2010
  • Operating cash flow of $15 million in the fourth quarter of 2011

Quaker Chemical Corporation (NYSE: KWR) today announced net sales of $173.3 million for the fourth quarter of 2011, up 22% compared to fourth quarter 2010 net sales of $142.1 million, and earnings per diluted share of $0.75 for the fourth quarter of 2011, up 27% compared to fourth quarter 2010 earnings per diluted share of $0.59. Full year net sales were $683.2 million for 2011, up 26% compared to prior year net sales of $544.1 million, and earnings per diluted share were $3.47 for 2011, up 25% compared to prior year earnings per diluted share of $2.77.

Michael F. Barry, Chairman, Chief Executive Office and President, commented, "Our fourth quarter bottom-line results were in line with our expectations. We saw softer volumes due to seasonality and customer actions to decrease inventory levels in the supply chain. We also experienced approximately $2.1 million of higher compensation costs in Q4 vs. Q3 primarily due to the appreciation of our stock price impacting the accrual for our long-term incentive plan and the timing of accruals for the annual incentive plan. In addition, we incurred approximately $0.6 million of acquisition related costs in the fourth quarter. On the positive side, we are continuing to gain new business and are making sequential progress in improving our gross margins. In addition, we had a lower tax rate and we are pleased with the contributions from our recent acquisitions."

Michael F. Barry, further stated, "2011 was a record year in terms of net sales and earnings for Quaker in a very challenging global environment. We overcame record levels of raw material increases and increased our volumes and market share, even excluding acquisitions. Our recent acquisitions have positioned us well for further product line and geographic expansion, and the equity offering completed earlier in 2011 further strengthened our balance sheet and provides us with the financial flexibility to take advantage of additional acquisitions and other growth opportunities as they arise."

Mr. Barry continued, "As we look to 2012, we see a mix of factors which could impact our results. The negatives include a sluggish global economy, especially in Europe, a lower rate of growth in China, escalating SG&A costs in emerging markets, and a stronger U.S. dollar. Offsetting these negatives are the continued recovery of manufacturing in North America, the full-year impact of acquisitions, as well as growth due to our investment in strategic initiatives. Overall, despite the challenging environment, our expectation for 2012 is for net income to surpass our 2011 net income of $40.9 million, which excludes the non-cash gain related to our Mexico acquisition, discussed below. In summary, I am confident in our future and expect 2012 will be another strong year for Quaker. "

Fourth Quarter Summary

Net sales for the fourth quarter of 2011 were approximately $173.3 million, an increase of $31.2 million, or 22% from the fourth quarter of 2010. Product volumes were approximately 14% higher, including acquisitions. Selling prices and mix increased revenues by approximately 9%, reflecting the Company's price increases during 2011 to help offset higher raw material costs. Foreign exchange rates decreased revenues by approximately 1%. On a sequential basis, volumes in North America, South America and Europe were seasonally lower than the third quarter.

Gross profit increased by approximately $8.8 million, or 18%, from the fourth quarter of 2010, but gross margin decreased from 33.7% to 32.7%. The decrease in gross margin was primarily driven by higher raw material costs compared to the prior year. Gross margin was slightly higher than the third quarter of 2011 as the Company experienced the full impact of recent pricing actions and some stabilization in raw material costs. However, this benefit was partially offset by mix and other factors.

Selling, general and administrative expenses ("SG&A") increased approximately $9.6 million compared to the fourth quarter 2010. SG&A expenses of the recent acquisitions and acquisition-related costs represented approximately 35% of the increase versus the fourth quarter of 2010 while higher incentive compensation costs accounted for more than 30%. While overall incentive compensation expense is lower in the full year 2011 compared to 2010, a higher percentage of incentive compensation costs were accrued earlier in the year in 2010 based on improved business performance. Higher selling costs related to increased business activity and inflationary and other costs accounted for the remainder of the increase.

Included in the results for the fourth quarter of 2010 is a non-income tax contingency charge of approximately $0.6 million, or $0.05 per diluted share.

Other income for the fourth quarter of 2011 includes a pre-tax $0.6 million, or $0.03 per diluted share, gain related to a fair value adjustment to a contingent consideration liability.

Equity in net income of associated companies in 2010 includes an out-of-period charge of $0.05 per diluted share.

Full Year Summary

Net sales for 2011 were approximately $683.2 million, an increase of $139.2 million, or 26%, from 2010. Product volumes were approximately 13% higher, including acquisitions. Selling prices and mix increased revenues by approximately 10%, as the Company increased prices to help offset higher raw material costs. Foreign exchange rates increased revenues by approximately 3%.

Gross profit increased by approximately $29.9 million, or 15%, from 2010, but gross margin decreased from 35.4% in 2010 to 32.6% as raw material costs continued to escalate.

SG&A increased approximately $25.5 million, or 18%, compared to 2010. Higher selling, inflationary and other costs as a result of increased business activity and investment in growth, acquisition-related activity and foreign exchange rate translation accounted for the majority of the increase while overall incentive compensation costs were lower. SG&A as a percentage of sales decreased from 25.6% in 2010 to 24.1% in 2011.

Included in the 2010 results is a non-income tax contingency charge of approximately $4.1 million, or $0.26 per diluted share, and a final charge related to the Company's former CEO's supplemental retirement plan of approximately $1.3 million, or $0.08 per diluted share.

Other income for 2011 includes a pre-tax $0.6 million, or $0.03 per diluted share, gain related to a fair value adjustment to a contingent consideration liability and a $2.7 million, or $0.22 per diluted share, non-cash gain representing the revaluation of the Company's previously held ownership interest in its Mexican equity affiliate to its fair value related to the July 2011 purchase of the remaining interest in this entity.

Interest expense decreased due to lower average borrowings. Equity in net income of associated companies in 2010 reflects the equity affiliate charge noted above, as well as a $0.03 per diluted share charge related to the first quarter 2010 devaluation of the Venezuelan Bolivar Fuerte.

Balance Sheet and Cash Flow Items

Operating cash flow increased by $15.1 million in the fourth quarter of 2011 on strong earnings and improvements in working capital. In addition, the Company completed the acquisition of G.W. Smith & Sons, Inc. for a purchase price of approximately $14.5 million. In the second quarter of 2011, the Company completed an equity offering of approximately 1.3 million shares, resulting in approximately $48.1 million of net cash proceeds, which were used to repay a portion of its revolving credit line. The fourth quarter 2011 and full year 2011 earnings per diluted share of $0.75 and $3.47, respectively, reflect an approximate $0.07 and $0.20 dilutive effect, respectively, as a result of the equity offering.

Non-GAAP Measures

Included in this public release is a non-GAAP financial measure of net income excluding a non-cash gain on the revaluation of a previously held ownership interest in a Mexican affiliate. The Company believes this non-GAAP measure enhances a reader's understanding of the financial performance of the Company, is more indicative of the future performance of the Company and facilitates a better comparison among fiscal periods. Non-GAAP results are presented for supplemental informational purposes only, and should not be considered a substitute for the financial information presented in accordance with GAAP. The following is a reconciliation between the non-GAAP (unaudited) financial measure of net income excluding a non-cash gain on the revaluation of a previously held ownership interest in a Mexican affiliate to its most comparable GAAP measure (in thousands):




Three Months Ended

December 31,


Twelve Months Ended

December 31,



2011


2010


2011


2010










Net income attributable to Quaker Chemical Corporation


$         9,770


$        6,895


$        43,569


$      31,807










Non-cash gain on the revaluation of a previously held ownership interest in a Mexican affiliate


-


-


(2,718)


-










Net income excluding a non-cash gain on the revaluation of a previously held ownership interest in a Mexican affiliate


$         9,770


$        6,895


$        40,851


$      31,807




Forward-Looking Statements

This release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected in such statements. A major risk is that the Company's demand is largely derived from the demand for its customers' products, which subjects the Company to downturns in a customer's business and unanticipated customer production shutdowns. Other major risks and uncertainties include, but are not limited to, significant increases in raw material costs, customer financial stability, worldwide economic and political conditions, foreign currency fluctuations, and future terrorist attacks such as those that occurred on September 11, 2001. Other factors could also adversely affect us. Therefore, we caution you not to place undue reliance on our forward-looking statements. This discussion is provided as permitted by the Private Securities Litigation Reform Act of 1995.

Conference Call

As previously announced, Quaker Chemical's investor conference call to discuss fourth quarter results is scheduled for March 8, 2012 at 8:30 a.m. (ET). A live webcast of the conference call, together with supplemental information, can be accessed through the Company's Investor Relations Web site at http://www.quakerchem.com. You can also access the conference call by dialing 877-269-7756.

About Quaker

Quaker Chemical Corporation is a leading global provider of process chemicals, chemical specialties, services, and technical expertise to a wide range of industries – including steel, aluminum, automotive, mining, aerospace, tube and pipe, coatings and construction materials. Our products, technical solutions and chemical management services enhance our customers' processes, improve their product quality and lower their costs. Quaker's headquarters is located near Philadelphia in Conshohocken, Pennsylvania.

Quaker Chemical Corporation

Condensed Consolidated Statement of Income

(Dollars in thousands, except per share data)





















(Unaudited)












Three Months Ended December 31,


Twelve Months Ended December 31,



2011


2010


2011


2010










Net sales


$                173,261


$                142,083


$                683,231


$                544,063










Cost of goods sold


116,597


94,193


460,581


351,274










Gross profit


56,664


47,890


222,650


192,789

%


32.7%


33.7%


32.6%


35.4%










Selling, general and administrative expenses


45,297


35,723


164,738


139,209

Non-income tax contingency charge


-


551


-


4,132

CEO transition costs


-


-


-


1,317










Operating income


11,367


11,616


57,912


48,131

%


6.6%


8.2%


8.5%


8.8%










Other income, net


980


540


5,050


2,106

Interest expense, net


(806)


(822)


(3,585)


(4,024)

Income before taxes and equity in net income of associated companies


11,541


11,334


59,377


46,213










Taxes on income before equity in net income of associated companies


1,295


3,631


14,256


12,616



10,246


7,703


45,121


33,597










Equity in net income (loss) of associated companies


64


(240)


779


494










Net income


10,310


7,463


45,900


34,091










Less: Net income attributable to noncontrolling interest


540


568


2,331


2,284










Net income attributable to Quaker Chemical Corporation


$                    9,770


$                    6,895


$                  43,569


$                  31,807

%


5.6%


4.9%


6.4%


5.8%










Per share data:









Net income attributable to Quaker Chemical Corporation Common Shareholders - basic


$                      0.76


$                      0.60


$                      3.52


$                      2.82

Net income attributable to Quaker Chemical Corporation Common Shareholders - diluted


$                      0.75


$                      0.59


$                      3.47


$                      2.77



Quaker Chemical Corporation

Condensed Consolidated Balance Sheet

(Dollars in thousands, except par value and share amounts)








(Unaudited)








December 31,


December 31,



2011


2010

ASSETS










Current assets





Cash and cash equivalents


$                16,909


$                25,766

Accounts receivable, net


150,676


116,266

Inventories, net


74,758


60,841

Current deferred tax assets


6,338


4,624

Prepaid expenses and other current assets


10,868


7,985

Total current assets


259,549


215,482






Property, plant and equipment, net


82,916


76,535

Goodwill


58,152


52,758

Other intangible assets, net


31,783


24,030

Investments in associated companies


7,942


9,218

Deferred income taxes


29,823


28,846

Other assets


35,356


42,561

Total assets


$              505,521


$              449,430






LIABILITIES AND EQUITY










Current liabilities





Short-term borrowings and current portion of long-term debt


$                     636


$                     890

Accounts and other payables


65,026


61,192

Dividends payable


3,099


2,701

Accrued compensation


16,987


17,140

Accrued pension and postretirement benefits


2,038


1,672

Current deferred tax liabilities


238


181

Other current liabilities


18,625


17,415

Total current liabilities


106,649


101,191

Long-term debt


46,701


73,855

Deferred income taxes


7,094


6,108

Accrued pension and postretirement benefits


34,533


30,016

Other non-current liabilities


54,818


51,161

Total liabilities


249,795


262,331






Equity





Common stock, $1 par value; authorized 30,000,000 shares; issued 2011 - 12,911,508 shares


12,912


11,492

Capital in excess of par value


89,725


38,275

Retained earnings


175,932


144,347

Accumulated other comprehensive loss


(29,820)


(13,736)

Total Quaker shareholders' equity


248,749


180,378

Noncontrolling interest


6,977


6,721

Total shareholders' equity


255,726


187,099

Total liabilities and equity


$              505,521


$              449,430








Quaker Chemical Corporation

Condensed Consolidated Statement of Cash Flows

For the twelve months ended December 31,

(Dollars in thousands)













(Unaudited)



2011


2010

Cash flows from operating activities





Net income


$        45,900


$        34,091

Adjustments to reconcile net income to net cash provided by operating activities:





Depreciation


11,455


9,867

Amortization


2,338


988

Equity in undistributed earnings of associated companies, net of dividends


(42)


19

Deferred income tax


2,431


1,849

Uncertain tax positions (non-deferred portion)


3,673


(1,130)

Deferred compensation and other, net


660


(628)

Stock-based compensation


3,513


3,096

Non-cash gain from purchase of equity affiliate


(2,718)


-

(Gain) loss on disposal of property, plant and equipment


(86)


32

Insurance settlement realized


(1,840)


(1,640)

Pension and other postretirement benefits


(4,239)


(2,636)

(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions:





Accounts receivable


(31,558)


(4,469)

Inventories


(9,281)


(7,153)

Prepaid expenses and other current assets


(2,505)


(814)

Accounts payable and accrued liabilities


4,442


5,511

Estimated taxes on income


(2,477)


564

Net cash provided by operating activities


19,666


37,547






Cash flows from investing activities





Investments in property, plant and equipment


(12,117)


(9,354)

Payments related to acquisitions


(25,477)


(35,909)

Proceeds from disposition of assets


393


229

Insurance settlement received and interest earned


80


5,122

Change in restricted cash, net


1,760


(1,124)

Net cash used in investing activities


(35,361)


(41,036)






Cash flows from financing activities





Net decrease in short-term borrowings


(254)


(1,456)

Proceeds from long-term debt


-


9,841

Repayments of long-term debt


(27,364)


(636)

Dividends paid


(11,586)


(10,449)

Stock options exercised, other


1,105


5,500

Excess tax benefit related to stock option exercises


109


2,558

Proceeds from sale of common stock, net of related expenses


48,143


-

Distributions to minority shareholders


(1,000)


(1,021)

Net cash provided by financing activities


9,153


4,337






Effect of exchange rate changes on cash


(2,315)


(133)

Net (decrease) increase in cash and cash equivalents


(8,857)


715

Cash and cash equivalents at the beginning of the period


25,766


25,051

Cash and cash equivalents at the end of the period


$        16,909


$        25,766










CONTACT: Mark A. Featherstone, Vice President and Chief Financial Officer, +1-610-832-4160